Piper Jaffray & Co. upgrades Affymetrix (Nasdaq: AFFX) to Overweight. Price target increased from $5 to $11.

Piper analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE